Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

Is Aurora Cannabis Stock Headed to $1 Per Share?

By George Budwell - Nov 19, 2019 at 7:43AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Aurora's shares took a beating last week -- industrywide headwinds could push it even lower.

Last week, Aurora Cannabis ( ACB 6.87% ) stock tumbled in response to both Canopy Growth's ( CGC 4.83% ) dreadful fiscal second-quarter earnings report, as well as its own weaker-than-expected fiscal first-quarter numbers. Aurora's shares, in fact, ended the week down by an eye-catching 28.3%. Aurora's shares have now fallen by a whopping 44% for the whole of 2019 -- making it one of the worst-performing mid-cap stocks currently listed on the New York Stock Exchange (NYSE) this calendar year.

Now, with the end of the year fast approaching, some investors might be tempted to cut their losses with this once-high-flying pot stock, especially if it would help to minimize their capital gains from other sources. Aurora's near-term prospects, after all, aren't particularly bright due to the ongoing structural issues within the legal Canadian marijuana market.

A hand holding a one dollar bill.

Image Source: Getty Images.

Fleshing out this point, the lack of sufficient numbers of retail outlets in most provinces, the slow rollout of Cannabis 2.0, and the exceedingly high price of most dried flower varieties -- compared to those on the black market -- have all acted in concert to force Aurora to rethink its business strategy heading into next year. The key point is that Aurora's shares may have a lot further to fall -- and they may even test the NYSE minimum bid requirement of $1 per share in the not-so-distant future.

So should investors hit the exits before Aurora's shares take another leg downward, or has this beaten-down pot stock finally bottomed out? Let's take a deeper look at Aurora's positives and negatives to find out.

Aurora: The bull and bear case

Aurora gave shareholders three reasons to believe that better days might be close at hand during its latest earnings release:

  1. The company struck a special stock conversion agreement in regards to its 230 million Canadian dollars' worth of convertible debentures set to mature next March. This special conversion deal significantly lowers the amount of cash Aurora will have to dole out on these convertible debentures early next year.
  2. The upcoming launch of Aurora's proprietary line of vapes, concentrates, gummies, chocolates, mints, and cookies -- as part of Cannabis 2.0 -- should provide a healthy bump in net income starting in the second half of the company's fiscal year.
  3. Aurora and Canopy's respective management teams have both noted that the provincial retail bottleneck should prove to be a short-term headwind.

The bear case essentially boils down to the fact that Aurora -- along with almost every major licensed Canadian producer -- has done an exceedingly poor job of foreseeing how the industry would evolve during this formative period. The net result is that the market's view of pot stocks has gone from irrational exuberance to outright pessimism ever since the end of the first quarter of 2019.

Buy or sell?

Aurora remains a promising long-term play that could pay off handsomely over the next decade. Nothing that has materialized in the past week changes that basic fact. Unfortunately, it also wouldn't be surprising if Aurora's stock starts to approach $1 per share within the next two months.

After all, Aurora is facing the prospect of becoming a top tax-loss selling candidate, sentiment has turned decidedly against pot stocks as a whole, and speculative growth stocks tend to fare poorly in an election year. Moreover, the true impact of Cannabis 2.0 won't starting showing up on earnings reports for another four full months.

Meanwhile, the moody market is likely to continue to act like a man with a hammer when it comes to pot stocks. That's not a promising setup for a company that still sports a rather rich valuation (price-to-sales ratio of 11.6) -- even after last week's enormous sell-off.

The good news is that Aurora would finally be in solid bargain territory at $1 per share (assuming no further dilution). As things stand now, Aurora would sport a below-average valuation for a consumer packaged goods stock at $1 per share (estimated price-to-sales ratio ranging from 1.10 to 2.17). So, if you're looking for a truly attractive buying opportunity, it might be a good idea to wait just a little bit longer to see if this stock does indeed enter clearance-bin territory.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Aurora Cannabis Stock Quote
Aurora Cannabis
$6.38 (6.87%) $0.41
Canopy Growth Stock Quote
Canopy Growth
$10.64 (4.83%) $0.49

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/07/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.